Author Correction: Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance.
Deng Y, Diepstraten ST, Potts MA, Giner G, Trezise S, Ng AP, Healey G, Kane SR, Cooray A, Behrens K, Heidersbach A, Kueh AJ, Pal M, Wilcox S, Tai L, Alexander WS, Visvader JE, Nutt SL, Strasser A, Haley B, Zhao Q, Kelly GL, Herold MJ.
Deng Y, et al. Among authors: alexander ws.
Nat Commun. 2022 Aug 25;13(1):5007. doi: 10.1038/s41467-022-32817-9.
Nat Commun. 2022.
PMID: 36008403
Free PMC article.
No abstract available.